BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 33680943)

  • 1. Intracavitary/Interstitial Applicator Plus Distal Parametrial Free Needle Interstitial Brachytherapy in Locally Advanced Cervical Cancer: A Dosimetric Study.
    Qu HD; Han DM; Zhang N; Mao Z; Cheng GH
    Front Oncol; 2020; 10():621347. PubMed ID: 33680943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can combined intracavitary/interstitial approach be an alternative to interstitial brachytherapy with the Martinez Universal Perineal Interstitial Template (MUPIT) in computed tomography-guided adaptive brachytherapy for bulky and/or irregularly shaped gynecological tumors?
    Oike T; Ohno T; Noda SE; Kiyohara H; Ando K; Shibuya K; Tamaki T; Takakusagi Y; Sato H; Nakano T
    Radiat Oncol; 2014 Oct; 9():222. PubMed ID: 25319341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computed Tomography-Guided Interstitial Brachytherapy for Locally Advanced Cervical Cancer: Introduction of the Technique and a Comparison of Dosimetry With Conventional Intracavitary Brachytherapy.
    Liu ZS; Guo J; Zhao YZ; Lin X; Zhang BY; Zhang C; Wang HY; Yu L; Ren XJ; Wang TJ
    Int J Gynecol Cancer; 2017 May; 27(4):768-775. PubMed ID: 28267131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiobiological and dosimetric comparison of 60Co versus 192Ir high-dose-rate intracavitary-interstitial brachytherapy for cervical cancer.
    Wen A; Wang X; Wang B; Yan C; Luo J; Wang P; Li J
    Radiat Oncol; 2022 Dec; 17(1):206. PubMed ID: 36514118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel minimally invasive dynamic-shield, intensity-modulated brachytherapy system for the treatment of cervical cancer.
    Morcos M; Antaki M; Viswanathan AN; Enger SA
    Med Phys; 2021 Jan; 48(1):71-79. PubMed ID: 32916763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rectal separation using hydroxypropyl methylcellulose in intracavitary brachytherapy of cervical cancer: an innovative approach.
    Basu S; Manir KS; Basu A; Ghosh K
    J Contemp Brachytherapy; 2016 Oct; 8(5):399-403. PubMed ID: 27895681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effectiveness and safety of image-based, transperineal combined intracavitary and interstitial brachytherapy in treatment of locally advanced cervical cancer.
    Tiwari R; Narayanan GS; Narayanan S; Suresh Kumar P
    Brachytherapy; 2020; 19(1):73-80. PubMed ID: 31813739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical use of the Utrecht applicator for combined intracavitary/interstitial brachytherapy treatment in locally advanced cervical cancer.
    Nomden CN; de Leeuw AA; Moerland MA; Roesink JM; Tersteeg RJ; Jürgenliemk-Schulz IM
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1424-30. PubMed ID: 21669505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes and comparison of dosimetric parameters between intracavitary (Fletcher) and combined intracavitary/interstitial (Utrecht) brachytherapy in locally advanced cervical cancer.
    Sarwar KA; Hussain S; Syed AS; Khan K; Maqsood T; Azeem T
    Brachytherapy; 2024; 23(1):10-17. PubMed ID: 37813708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical feasibility of interstitial brachytherapy using a "hybrid" applicator combining uterine tandem and interstitial metal needles based on CT for locally advanced cervical cancer.
    Liu ZS; Guo J; Lin X; Wang HY; Qiu L; Ren XJ; Li YF; Zhang BY; Wang TJ
    Brachytherapy; 2016; 15(5):562-9. PubMed ID: 27474180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of clinical utilization of ring applicator for combined intracavitary/interstitial image-guided brachytherapy treatment in Chinese patients with locally advanced cervical cancer.
    Zhao Z; Zhang N; Liu Y; Wu N; Mao Z; Yang W; Cheng G
    J Contemp Brachytherapy; 2020 Jun; 12(3):252-259. PubMed ID: 32695197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early outcomes and impact of a hybrid IC/IS applicator for a new MRI-based cervical brachytherapy program.
    Harkenrider MM; Surucu M; Harmon G; Mysz ML; Shea SM; Yacoub J; Goldberg A; Liotta M; Winder A; Potkul R; Roeske JC; Small W
    Brachytherapy; 2018; 17(1):187-193. PubMed ID: 29089277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose coverage comparison between "interstitial catheter-only" and "hybrid intracavitary-interstitial brachytherapy" for early stage squamous cell carcinoma of the buccal mucosa.
    Murakami N; Ueno T; Yatsuoka W; Okamoto H; Tselis N; Masui K; Yoshida K; Takahashi K; Inaba K; Okuma K; Igaki H; Nakayama Y; Itami J
    J Contemp Brachytherapy; 2018 Oct; 10(5):486-491. PubMed ID: 30479628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric impact of applicator displacement on three-dimensional image-guided high-dose-rate brachytherapy treatments for cervical cancer.
    Jayarathna S; Hoang M; Badkul R; Hoover A
    J Contemp Brachytherapy; 2023 Oct; 15(5):334-343. PubMed ID: 38026073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical needle selection for Vienna-style applicators: improving therapeutic ratio in hybrid intracavitary-interstitial brachytherapy.
    Martin DA; Taunk NK; Anamalayil S; Mangal V; Marcel J; Hubley E
    J Contemp Brachytherapy; 2021 Oct; 13(5):533-540. PubMed ID: 34759978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Boost modalities in cervical cancer: dosimetric comparison between intracavitary BT vs. intracavitary + interstitial BT vs. SBRT.
    Benkhaled S; Diakité K; Jullian N; Poeta S; Vandekerkhove C; Van Houtte P; Van Gestel D; De Caluwé A
    Radiat Oncol; 2023 Jun; 18(1):105. PubMed ID: 37381016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of dose-effect relationship between DVH parameters and clinical prognosis of definitive radio(chemo)therapy combined with intracavitary/interstitial brachytherapy in patients with locally advanced cervical cancer: A single-center retrospective study.
    Zhang N; Tang Y; Guo X; Mao Z; Yang W; Cheng G
    Brachytherapy; 2020; 19(2):194-200. PubMed ID: 31791712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Point A vs. HR-CTV D
    Harmon G; Diak A; Shea SM; Yacoub JH; Small W; Harkenrider MM
    Brachytherapy; 2016; 15(6):825-831. PubMed ID: 27693173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venezia applicator with oblique needles improves clinical target volume coverage in distal parametrial tumor residue compared to parallel needles only.
    Kissel M; Fournier-Bidoz N; Henry O; Bockel S; Kumar T; Espenel S; Chargari C
    J Contemp Brachytherapy; 2021 Feb; 13(1):24-31. PubMed ID: 34025733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implementation of three-dimensional standardized template-guided brachytherapy for patients with locally advanced cervical cancer.
    Tu Y; Wang J; Chen Y; Chen Y; Tang Q
    J Contemp Brachytherapy; 2023 Dec; 15(6):405-413. PubMed ID: 38230396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.